Oxford Biotrans Ltd. is a biotechnology startup that was founded in 2013 as a University of Oxford spin-out company. The company is backed by over 15 years of research by Dr Luet Lok Wong from the Department of Chemistry at the University of Oxford. Oxford Biotrans specializes in the development and commercialization of enzymatic process technologies that result in the production of high-value chemical compounds. The latest funding round for the company was a £2.10M Series B investment on 10 October 2017, with funding contributed by Perivoli Innovations, Touchstone Innovations, Oxford Investment Consultants LLP, and the University of Oxford. The company operates in the biotechnology and education sectors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | £2.10M | 4 |
|
10 Oct 2017 |
| Series A | £2.50M | 1 | Imperial Innovations | 04 Aug 2015 |
| Seed Round | £600.00K | - | 01 Oct 2013 |
No recent news or press coverage available for Oxford Biotrans Ltd..
We care about your data, and we'd love to use cookies make your experience better.
